193 related articles for article (PubMed ID: 29274237)
21. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
22. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
23. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 1,3-thiazine derivatives and their evaluation as potential antimycobacterial agents.
Koketsu M; Tanaka K; Takenaka Y; Kwong CD; Ishihara H
Eur J Pharm Sci; 2002 Apr; 15(3):307-10. PubMed ID: 11923063
[TBL] [Abstract][Full Text] [Related]
25. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
26. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
[TBL] [Abstract][Full Text] [Related]
28. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
33. Novel benzoxazoles: synthesis and antibacterial, antifungal, and antitubercular activity against antibiotic-resistant and -sensitive microbes.
Arisoy M; Temiz-Arpaci O; Kaynak-Onurdag F; Ozgen S
Z Naturforsch C J Biosci; 2013; 68(11-12):453-60. PubMed ID: 24601083
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
35. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
[TBL] [Abstract][Full Text] [Related]
36. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
37. [Antimycobacterial activities of a new quinolone, sparfloxacin].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
[TBL] [Abstract][Full Text] [Related]
38. Antimycobacterial activity: a facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines.
Wei AC; Ali MA; Yoon YK; Ismail R; Choon TS; Kumar RS; Arumugam N; Almansour AI; Osman H
Bioorg Med Chem Lett; 2012 Aug; 22(15):4930-3. PubMed ID: 22749825
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitubercular activities of bis-glycosylated diamino alcohols.
Tripathi RP; Tiwari VK; Tewari N; Katiyar D; Saxena N; Sinha S; Gaikwad A; Srivastava A; Chaturvedi V; Manju YK; Srivastava R; Srivastava BS
Bioorg Med Chem; 2005 Oct; 13(19):5668-79. PubMed ID: 15955703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
